(Q51907614)

17 April 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Atypical antipsychotic drugs and Alzheimer's disease. (English)

1 reference

17 April 2018

Atypical antipsychotic drugs and Alzheimer's disease (English)

0 references

author name string

Maria C Jockers-Scherübl

1

1 reference

17 April 2018

Rainer Hellweg

2

1 reference

17 April 2018

Hadi Meeran Hussain

1

0 references

Matthew Hotopf

2

0 references

Femi Oyebode

3

0 references

language of work or name

English

0 references

publication date

1 January 2007

1 reference

17 April 2018

The New England Journal of Medicine

25 January 2007

0 references

published in

1 reference

17 April 2018

volume

356

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

416-7; author reply 417-8

1 reference

17 April 2018

Old and ill and still feeling well? Determinants of subjective well-being in >or=60 year olds: the role of the sense of coherence.

416; author reply 417-8

0 references

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Atypical antipsychotics in Parkinson-sensitive populations

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Alzheimer's disease--clinical trials and the logic of clinical purpose.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Antipsychotic drugs in dementia: what should be made of the risks?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Atypical antipsychotics for aggression and psychosis in Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1056/NEJMC063094

Identifiers

DOI

10.1056/NEJMC063094

1 reference

17 April 2018

1 reference

17 April 2018